Title:
HETEROCYCLIC AMIDE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2018/052066
Kind Code:
A1
Abstract:
Provided is a heterocyclic compound that can have a PRS inhibitory effect and is expected to be of use as a prophylaxis or a therapeutic agent for PRS-related diseases, including cancer. A compound or a salt thereof, said compound being expressed by formula (I) (wherein each symbol is as indicated in the specification).
Inventors:
HIRAYAMA TAKAHARU (JP)
HIRATA YASUHIRO (JP)
TOMINARI YUSUKE (JP)
IWAMURA NAOKI (JP)
SASAKI YUSUKE (JP)
ASANO MORITERU (JP)
TAKAGI TERUFUMI (JP)
OKANIWA MASANORI (US)
YOSHIDA MASATO (JP)
IMAMURA SHINICHI (JP)
HIRATA YASUHIRO (JP)
TOMINARI YUSUKE (JP)
IWAMURA NAOKI (JP)
SASAKI YUSUKE (JP)
ASANO MORITERU (JP)
TAKAGI TERUFUMI (JP)
OKANIWA MASANORI (US)
YOSHIDA MASATO (JP)
IMAMURA SHINICHI (JP)
Application Number:
PCT/JP2017/033214
Publication Date:
March 22, 2018
Filing Date:
September 14, 2017
Export Citation:
Assignee:
TAKEDA PHARMACEUTICALS CO (JP)
International Classes:
C07D401/04; A61K31/4439; A61K31/444; A61K31/506; A61P35/00; A61P43/00; C07D401/14; C07D403/04; C07D403/14; C07D405/14; C07D409/14; C07D417/14; C12N9/99
Domestic Patent References:
| WO2015016206A1 | 2015-02-05 | |||
| WO2008044700A1 | 2008-04-17 | |||
| WO2015199418A2 | 2015-12-30 | |||
| WO2010019210A2 | 2010-02-18 |
Other References:
See also references of EP 3514150A4
Attorney, Agent or Firm:
TAKASHIMA, Hajime et al. (JP)
Download PDF: